Zobrazeno 1 - 10 of 179 pro vyhledávání: '"KARAMANOLIS D"'
4
Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms
Autor: VAKIL N, TALLEY N, VAN ZANTEN SV, FLOOK N, PERSSON T, BJÖRCK E, LIND T, BOLLING STERNEVALD E, STARS I. STUDY GROUP: BAI JC, SEGAL E, DI RISIO C, PEDRANA R, RAINOLDI J, MILUTIN M, PALAZZO F, MACKEN E, BAETENS P, D'HAENS G, CABOOTER M, MARTINET JP, DELWAIDE J, PIESSEVAUX H, BUSET M, JANSSENS J, VERGAUWE P, POLLET S, QUILICI F, RODRIGUEZ TN, DA SILVA EP, NADER F, LUIZ JORGE J, ACHILLES P, CORRÊA BL, GUEDES J, CLARK D, PLOURDE, DESAI M, MORGAN EP, GRAY J, COHEN A, REDDY S, JOBIN G, SADOWSKI D, KELLY A, MORGAN D, ING G, LIANG W, TYTUS R, TEITELBAUM I, LASKO B, KASSNER R, CARLSON B, O'KEEFE D, SOMANI R, GREENSPOON A, FAIERS A, BANKS M, JARDINE F, WOODLAND R, LUCES K, COX R, ROLFE A, FAY D, AKHRAS D, MAZZA G, KIILERICH S, BYTZER P, HENDEL L, ERIKSEN J, THORDAL C, VADSTRUP S, FLY G, GOLDFAIN D, COULANJON G, LEOTHAUD G, DELETTE O, MATHONIERE O, ZRIHEN D, LEMAITRE JP, PEIGNOT JF, BARBERIS A, TORDJMAN G, GOMPEL M, GRANDGUILLAUME J, MARCIANO P, LE TEXIER A, BOYE A, TONDUT A, SCHEER J, SCHMIDT W, KÖLLING W, REGLING S, ALASMAR D, BECKER TESCH A, LEHMANN R, SCHIRRMEISTER G, SPEETZEN G, STAHL HD, ROITENBERG A, KITIS GE, KARAMANOLIS D, TRIANTAFILLOU G, TZIVRAS M, AVGERINOS A, BJÖRNSSON ORVAR K, KRISTJÁNSDÓTTIR, BIRGISSON, VALDIMARSSON, BJÖRNSSON S, SPISNI R, SCARPULLA G, MINOLI G, DELLA BIANCA G, BIANCO MA, PISTOIA MA, VAIRA D, LONGHINI A, CESTARI R, JOMAAS H, JOHANSEN Y, LIER J, LØLAND O, SKJEGSTAD E, JØRUM IM, FONNELØP H, WANGESTAD M, TOMASSEN ST, NORDSTRAND A, HERTZENBERG AB, SAEBØ L, MANSILLA TINOCO R, NORHEIM PD, SOLNØR L, LUNDBY B, TOMALA T, SANAKER H, FAUSKE J, OSHAUG M, LINDSTRØM M, RUDNEVA E, HANSEN AN, SKAG A, WERNER EL, AHLQVIST JO, BØ PE, KJØRLAUG K, EIKELAND T, HATLEBREKKE T, OLSEN K, TUDOR N, DOBRU D, REDIS R, COMAN F, BALADAS H, FOCK KW, HO LK, LIM CC, GROBLER S, ALLY R, ABOO N, VAN RENSBURG C, MOHAME H, SCHNEIDER H, PRINS M, MOOLA S, BEKKER J, ABAD A, MEARIN MANRIQUE F, DOMINGUEZ E, HERRERIAS GUTIÉRREZ JM, DIAZ RUBIO M, WEDÉN M, EDIN R, UNG KA, TOTH E, JOHNSSON F, STUBBERÖD A, TOUR R, FALK A, HULTBER C, LARNEFELDT H, LÖNNEBORG L, ERICSSON M, KNUTSSON AC, FRÖBERG L, LARSSON A, TRACZ S, HOLLENBERG S, WIDE S, POLHEM B, PAULSSON L, GRIMFORS S, ROOS H, SKALENU JO, WEBER KB, STANGHELLINI, VINCENZO
BACKGROUND & AIMS: Current guidelines recommend empirical, noninvasive approaches to manage dyspeptic patients without alarm symptoms, but concerns about missed lesions persist; the cost savings afforded by noninvasive approaches must be weighed agai
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33162d6e6bf239aff2c5e76d848677a
http://hdl.handle.net/11379/38640
Zobrazit plný text záznamu
5
Vedolizumab as induction and maintenance therapy for ulcerative colitis
Autor: Feagan, Bg, Rutgeerts, P, Sands, Be, Hanauer, S, Colombel, Jf, Sandborn, Wj, Van Assche, G, Axler, J, Kim, Hj, Danese, S, Fox, I, Milch, C, Sankoh, S, Wyant, T, Xu, J, Parikh, A, Bampton P, GEMINI 1 Study G. r. o. u. p., Chung, A, Debinski, H, Florin, T, Hetzel, D, Kronborg, I, Lawrance, I, Leong, R, Macrae, F, Moore, G, Pavli, P, Radford Smith, G, Weltman, M, Haas, T, Reinisch, W, Stockenhuber, F, Vogel, W, De Maeyer, M, De Vos, M, D'Haens, G, Louis, E, Muls, V, Petrov, P, Aumais, G, Bitton, A, Bourdages, R, Bressler, B, Cohen, A, Fedorak, R, Greenberg, G, Jones, J, Kutcher, W, Macintosh, D, Ponich, T, Singh, R, Steinhart, H, Sy, R, Douda, L, Lukas, M, Samek, M, Vyhnalek, P, Woznica, V, Zadorova, Z, Andersen, V, Rannem, T, Staun, M, Maelt, A, Margus, B, Bonaz, B, Coffin, B, Desreumaux, P, Laharie, D, Reimund, Jm, Karaus, M, Pace, A, Ross, M, Schmidt, W, Witthoeft, T, Zeitz, M, Karamanolis, D, Mantzaris, G, Maris, T, Ng, C, Gall, J, Hunyady, B, Szepes, A, Toth, T, Vincze, A, Oddsson, E, Jósefsspktali, Kö, Ahuja, V, Amarapurkar, D, Goenka, M, Habeeb, Ma, Jalihal, U, Kalambe, B, Koshy, A, Kumar, R, Prasad, V, Reddy, N, Sekar, T, Shankar, R, Tantry, V, Ryan, B, Avni, Y, Ben Horin, S, Ardizzone, S, Armuzzi, A, Corazziari, E, Fries, Walter, Kohn, A, Lisova, D, George, Am, Hilmi, In, Bhaskaran, Sk, Soon, Sy, Engels, L, Ponsioen, C, Wallace, I, Wyeth, J, Florholmen, J, Jahnsen, J, Lygren, I, Röseth, A, Ciecko Michalska, I, Gonciarz, M, Huk, J, Jamrozik Kruk, Z, Kondusz Szklarz, M, Paradowski, L, Wiechowska Kozlowska, A, Han, Ds, Hong, Sp, Kim, Js, Kim, Ko, Kim, Yh, Yang, Sk, Alexeeva, O, Bunkova, E, Burnevich, E, Dolgikh, O, Kasherininova, I, Khovaeva, Y, Lakhin, A, Ling, Kl, Bester, F, Coetzer, T, Grundling Hde, K, Jackson, Ld, Spies, P, Wright, Jp, Ziady, C, Garcia Planella, E, Perez Gisbert, J, Rogler, G, Seibold, F, Kao, Aw, Wu, Dc, Atug, O, Kurdas, Oo, Hawthorne, Ab, Lindsay, J, Abreu, M, Aggarwal, A, Bala, N, Becker, S, Behm, B, Braun, R, Cohn, W, Cross, R, Dar, S, Dassopoulos, T, De Villiers, W, Desta, T, Dryden, G, Duvall, A, Farraye, F, Fein, S, Liu, Bf, Gatof, D, Geenen, D, Ginsburg, P, Glover, S, Gopal, V, Hanson, J, Hardi, R, Isaacs, K, Jain, R, Karyotakis, N, Korzenik, J, Koshy, G, Koval, G, Lawitz, E, Lee, S, Loftus, E, Luther, R, Mahadevan, U, Mannon, P, Matsuyama, R, Mcintosh, A, Melmed, G, Mirkin, K, Nichols, M, Oubre, B, Pandak, W, Quadri, A, Quallich, L, Randall, C, Rausher, D, Regueiro, M, Safdi, A, Sands, B, Scherl, E, Schneier, J, Schwartz, D, Sedghi, S, Shafran, I, Siegel, C, Stein, L, Tatum, H, Weinberg, D, Winston, B, Wolf, D, Younes, Z, Jewell, D, Mahon, J, Rothstein, R, Snydman, D, Massaro, J, Clifford, D, Berger, J, Major, E, Provenzale, J, Abstract, Lev M.
Publikováno v: Feagan, B G, Rutgeerts, P, Sands, B E, Hanauer, S, Colombel, J-F, Sandborn, W J, Van Assche, G, Axler, J, Kim, H-J, Danese, S, Fox, I, Milch, C, Sankoh, S, Wyant, T, Xu, J, Parikh, A, GEMINI 1 Study Group & Andersen, V 2013, ' Vedolizumab as induction and maintenance therapy for ulcerative colitis ', The New England Journal of Medicine, vol. 369, no. 8, pp. 699-710 . https://doi.org/10.1056/NEJMoa1215734
Gut-selective blockade of lymphocyte trafficking by vedolizumab may constitute effective treatment for ulcerative colitis.We conducted two integrated randomized, double-blind, placebo-controlled trials of vedolizumab in patients with active disease.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f535f6a4645de35bab1c956ec0c8158
https://pubmed.ncbi.nlm.nih.gov/23964940
Zobrazit plný text záznamu
9
Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
Autor: Vlachogiannakos, J. Saveriadis, A. S. Viazis, N. and Theodoropoulos, I. Foudoulis, K. Manolakopoulos, S. Raptis, S. Karamanolis, D. G.
Endotoxaemia is commonly seen in cirrhotic patients with ascites and this may be associated with increased portal pressure. To investigate the effect of intestinal decontamination on liver haemodynamics in alcohol-related cirrhotic patients with asci
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cac533261e6afd820a569b86f8454ae7
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3142143
Zobrazit plný text záznamu
10
Evaluation of forest ecosystem for water and wood production
Autor: KARAMANOLIS D.
Publikováno v: Вестник Поволжского государственного технологического университета. Серия: Лес. Экология. Природопользование.
The aim of this work was to study the process of producing wood and water from the University Forest of Taxiarchi Chalkidikis with the help of multiple decision support, part of which was the pairwise comparison method and to find which forest units
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2806::c36e31f6be685042e63e712b3693e758
http://cyberleninka.ru/article/n/evaluation-of-forest-ecosystem-for-water-and-wood-production
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje